Rivero Mestre announces that it has filed a putative class-action lawsuit against several manufacturers and distributors of contaminated Valsartan, a generic drug used to treat high blood pressure.

The FDA has issued one of the largest Class I recalls in history as almost half of the Valsartan currently being sold in the United States contains an impurity that is classified as a human carcinogen. Andrés Rivero, Jorge A. Mestre, Alan H. Rolnick, and Charlie Whorton of Rivero Mestre along with their co-counsel, MSP Recovery Law Firm, seek relief for a putative class of insurers and consumers who were unlawfully induced to pay for adulterated and dangerous Valsartan.

About Rivero Mestre LLP

Rivero Mestre, with offices in Miami and New York, represents clients from investigation to verdict and appeal in complex business disputes in U.S. federal courts, state courts, and domestic and international arbitration proceedings. The firm’s practice focuses primarily on representing corporate and institutional clients in a broad range of complex commercial disputes including financial institution matters, intellectual property disputes, and litigation and arbitration relating to Latin American trade and investment.